Citation: Sh. Caldwell et Sj. Bickston, Cholangioscopy to screen for cholangiocarcinoma in primary sclerosing cholangitis, LIVER TRANS, 7(4), 2001, pp. 380-380
Authors:
Caldwell, SH
Hespenheide, EE
Harris, D
De Lange, EE
Citation: Sh. Caldwell et al., Imaging and clinical characteristics of focal atrophy of segments 2 and 3 in primary sclerosing cholangitis, J GASTR HEP, 16(2), 2001, pp. 220-224
Authors:
Caldwell, SH
Hespenheide, ER
Von Borstel, RW
Citation: Sh. Caldwell et al., Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simavastatin, DIG DIS SCI, 46(2), 2001, pp. 376-378
Citation: Sh. Caldwell, Controlling pain in liver biopsy, or "We will probably need to repeat the biopsy in a year or two to assess the response", AM J GASTRO, 96(5), 2001, pp. 1327-1329
Authors:
Caldwell, SH
Hespenheide, EE
Redick, JA
Iezzoni, JC
Battle, EH
Sheppard, BL
Citation: Sh. Caldwell et al., A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis, AM J GASTRO, 96(2), 2001, pp. 519-525
Authors:
Harris, DM
Hespenheide, EE
Dalkin, AC
Kirk, SE
Ellis, DS
Caldwell, SH
Citation: Dm. Harris et al., Hyperthyroidism with interferon-ribavirin therapy for hepatitis C: A case report and proposed treatment algorithm, AM J GASTRO, 95(10), 2000, pp. 2995-2996
Authors:
Falstrom, JK
Moore, MM
Caldwell, SH
Matsumoto, AH
Abbott, RD
Spotnitz, WD
Citation: Jk. Falstrom et al., Use of fibrin sealant to reduce bleeding after needle liver biopsy in an anticoagulated canine model: Work in progress, J VAS INT R, 10(4), 1999, pp. 457-462
Authors:
Caldwell, SH
Oelsner, DH
Iezzoni, JC
Hespenheide, EE
Battle, EH
Driscoll, CJ
Citation: Sh. Caldwell et al., Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease, HEPATOLOGY, 29(3), 1999, pp. 664-669